These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 15825666)

  • 1. Prescribing. Switching schizophrenia treatments.
    Marven M
    Health Serv J; 2005 Mar; 115(5948):suppl 12. PubMed ID: 15825666
    [No Abstract]   [Full Text] [Related]  

  • 2. Mental health. Special agents.
    Bryan J
    Health Serv J; 1999 Jan; 109(5639):suppl 4-6. PubMed ID: 10345647
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparative effectiveness of antipsychotic drugs. A commentary on: Cost Utility Of The Latest Antipsychotic Drugs In Schizophrenia Study (CUtLASS 1) and Clinical Antipsychotic Trials Of Intervention Effectiveness (CATIE).
    Lieberman JA
    Arch Gen Psychiatry; 2006 Oct; 63(10):1069-72. PubMed ID: 17015808
    [No Abstract]   [Full Text] [Related]  

  • 4. Generic replacement of clozapine: a simple decision model from a Canadian perspective.
    Layton S; Barbeau M
    Curr Med Res Opin; 2004 Apr; 20(4):453-9. PubMed ID: 15119982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clozapine and hospitalization.
    Rosenheck R; Charney D; Cramer J
    Psychiatr Serv; 1999 Jan; 50(1):114-6. PubMed ID: 9890595
    [No Abstract]   [Full Text] [Related]  

  • 6. Why don't we use clozapine more often?
    Sajatovic M
    Psychiatr Serv; 2014 Feb; 65(2):135. PubMed ID: 24492895
    [No Abstract]   [Full Text] [Related]  

  • 7. Interpretation of analysis.
    Heller JG
    Can J Clin Pharmacol; 2002; 9(3):129, 153; author reply 153. PubMed ID: 12474874
    [No Abstract]   [Full Text] [Related]  

  • 8. Each of the following statements about the newer medications for schizophrenia, risperidone (risperidol) and clozapine (clozaril), is true, except: Patients receiving risperidone are at risk for agranulocytosis.
    Can Fam Physician; 1995 Oct; 41():1678, 1680. PubMed ID: 8829578
    [No Abstract]   [Full Text] [Related]  

  • 9. Modelling the impact of clozapine on suicide in patients with treatment-resistant schizophrenia in the UK.
    Duggan A; Warner J; Knapp M; Kerwin R
    Br J Psychiatry; 2003 Jun; 182():505-8. PubMed ID: 12777341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clozapine--should race affect prescribing guidelines?
    Mallinger JB; Lamberti JS
    Schizophr Res; 2006 Mar; 83(1):107-8. PubMed ID: 16520022
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacoeconomic evaluation of clozapine in treatment-resistant schizophrenia: a cost-utility analysis.
    Oh PI; Iskedjian M; Addis A; Lanctôt K; Einarson TR
    Can J Clin Pharmacol; 2001; 8(4):199-206. PubMed ID: 11743592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Refractory schizophrenia: what works pharmacologically?
    Sousa S
    J Psychosoc Nurs Ment Health Serv; 1999 Feb; 37(2):19-23. PubMed ID: 10023603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Medico-economic study of Léponex (clozapine) in the Bordeaux Charles Perrens Hospital Center].
    Bret P; Jolivel C; Bret MC; Veylit S; Martin C; Garcia P
    Encephale; 1998; 24(4):365-77. PubMed ID: 9809242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Business Case for Expanded Clozapine Utilization.
    Gören JL; Rose AJ; Smith EG; Ney JP
    Psychiatr Serv; 2016 Nov; 67(11):1197-1205. PubMed ID: 27301766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Switching antipsychotic medications.
    Weiden PJ; Aquila R; Dalheim L; Standard JM
    J Clin Psychiatry; 1997; 58 Suppl 10():63-72. PubMed ID: 9265919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health status and health care costs for publicly funded patients with schizophrenia started on clozapine.
    Blieden N; Flinders S; Hawkins K; Reid M; Alphs LD; Arfken CL
    Psychiatr Serv; 1998 Dec; 49(12):1590-3. PubMed ID: 9856622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clozapine for refractory schizophrenia: the Illinois experience.
    Buckman RW; Malan RD
    J Clin Psychiatry; 1999; 60 Suppl 1():18-22; discussion 28-30. PubMed ID: 10037166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A dilemma born of progress: switching from clozapine to a newer antipsychotic.
    Rafal S; Tsuang MT; Carpenter WT
    Am J Psychiatry; 1999 Jul; 156(7):1086-90. PubMed ID: 10401457
    [No Abstract]   [Full Text] [Related]  

  • 19. Cost-effectiveness of clozapine therapy for severe psychosis.
    Ghaemi SN; Ziegler DM; Peachey TJ; Goodwin FK
    Psychiatr Serv; 1998 Jun; 49(6):829-31. PubMed ID: 9634167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of Clozapine Funding in Southwestern Ontario.
    Pallaveshi L; Mak M; Rudnick A
    Psychiatr Serv; 2016 Jan; 67(1):143-4. PubMed ID: 26725498
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.